Lenalidomide monotherapy for relapsed/refractory peripheral T-cell lymphoma not otherwise specified

被引：41
|
作者：
Zinzani, Pier Luigi [1 ]
Pellegrini, Cinzia [1 ]
Broccoli, Alessandro [1 ]
Stefoni, Vittorio [1 ]
Gandolfi, Letizia [1 ]
Quirini, Federica [1 ]
Argnani, Lisa [1 ]
Berti, Emilio [2 ]
Derenzini, Enrico [1 ]
Pileri, Stefano [1 ]
Baccarani, Michele [1 ]
机构：
[1] Univ Bologna, Inst Hematol & Med Oncol L&A Seragnoli, I-40138 Bologna, Italy
[2] Univ Milano Bicocca, IRCCS Osped Maggiore, Milan, Italy
来源：
LEUKEMIA & LYMPHOMA | 2011年 / 52卷 / 08期
关键词：
GEMCITABINE; REGIMEN;
D O I：
10.3109/10428194.2011.573031
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1585 / 1588
页数：4
相关论文
共 50 条
  • [31] Primary breast peripheral T-cell lymphoma not otherwise specified: report of a case
    Daisuke Muroya
    Uhi Toh
    Nobutaka Iwakuma
    Shino Nakagawa
    Mai Mishima
    Ryuji Takahashi
    Miki Takenaka
    Kazuo Shirouzu
    Yoshito Agaki
    Surgery Today, 2015, 45 : 115 - 120
  • [32] A naturally occurring canine model of peripheral T-cell lymphoma, not otherwise specified
    Owens, Eileen
    Harris, Adam
    Avery, Anne
    CANCER RESEARCH, 2024, 84 (06)
  • [33] A Naturally Occurring Canine Model of Peripheral T-Cell Lymphoma Not Otherwise Specified
    Harris, Lauren
    Rout, Emily
    Yoshimoto, Janna
    Avery, Anne
    BLOOD, 2018, 132
  • [34] A case of peripheral T-cell lymphoma, not otherwise specified, with rapid progression to erythroderma
    Takeshi Namiki
    Takashi Hashimoto
    Makiko Nishida
    Tsukasa Ugajin
    Keiko Miura
    Hiroo Yokozeki
    European Journal of Dermatology, 2018, 28 : 240 - 241
  • [35] Histone modifier gene mutations in peripheral T-cell lymphoma not otherwise specified
    Ji, Meng-Meng
    Huang, Yao-Hui
    Huang, Jin-Yan
    Wang, Zhao-Fu
    Fu, Di
    Liu, Han
    Liu, Feng
    Leboeuf, Christophe
    Wang, Li
    Ye, Jing
    Lu, Yi-Ming
    Janin, Anne
    Cheng, Shu
    Zhao, Wei-Li
    HAEMATOLOGICA, 2018, 103 (04) : 679 - 687
  • [36] Primary breast peripheral T-cell lymphoma not otherwise specified: report of a case
    Muroya, Daisuke
    Toh, Uhi
    Iwakuma, Nobutaka
    Nakagawa, Shino
    Mishima, Mai
    Takahashi, Ryuji
    Takenaka, Miki
    Shirouzu, Kazuo
    Agaki, Yoshito
    SURGERY TODAY, 2015, 45 (01) : 115 - 120
  • [37] Primary Cutaneous Peripheral T-Cell Lymphoma Not Otherwise Specified: A Rapidly Progressive Variant of Cutaneous T-Cell Lymphoma
    Aderhold, Kimberly
    Carpenter, Lisa
    Brown, Krysta
    Donato, Anthony
    CASE REPORTS IN ONCOLOGICAL MEDICINE, 2015, 2015
  • [38] Peripheral T-cell lymphoma, not otherwise specified: A clinicopathologic study of 340 cases from the International Peripheral T-cell lymphoma Project
    Weisenburger, D. D.
    Vose, J. M.
    Armitage, J. O.
    ANNALS OF ONCOLOGY, 2008, 19 : 119 - 119
  • [39] Impact of Epstein-Barr Virus on Peripheral T-Cell Lymphoma Not Otherwise Specified and Angioimmunoblastic T-Cell Lymphoma
    Kim, Tong-Yoon
    Min, Gi-June
    Jeon, Young-Woo
    Park, Sung-Soo
    Park, Silvia
    Shin, Seung-Hawn
    Yahng, Seung-Ah
    Yoon, Jae-Ho
    Lee, Sung-Eun
    Cho, Byung-Sik
    Eom, Ki-Seong
    Kim, Yoo-Jin
    Lee, Seok
    Kim, Hee-Je
    Min, Chang-Ki
    Lee, Jong-Wook
    Cho, Seok-Goo
    FRONTIERS IN ONCOLOGY, 2022, 11
  • [40] Mogamulizumab Monotherapy in the Treatment of Relapsed/Refractory Peripheral T-Cell Lymphoma or Cutaneous T-Cell Lymphoma Patients in Single-Institution Experience
    Murai, Kazunori
    Hiroyuki, Hamada
    Sato, Akiyoshi
    Yasuro, Miyairi
    Mori, Yasuki
    Sakuma, Tsutomu
    BLOOD, 2017, 130
12345